Kesavan Esuvaranathan

1.7k total citations
64 papers, 1.3k citations indexed

About

Kesavan Esuvaranathan is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Kesavan Esuvaranathan has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 25 papers in Molecular Biology and 16 papers in Immunology. Recurrent topics in Kesavan Esuvaranathan's work include Bladder and Urothelial Cancer Treatments (33 papers), Cancer Research and Treatments (13 papers) and Epigenetics and DNA Methylation (9 papers). Kesavan Esuvaranathan is often cited by papers focused on Bladder and Urothelial Cancer Treatments (33 papers), Cancer Research and Treatments (13 papers) and Epigenetics and DNA Methylation (9 papers). Kesavan Esuvaranathan collaborates with scholars based in Singapore, United Kingdom and Australia. Kesavan Esuvaranathan's co-authors include Ratha Mahendran, Edmund Chiong, Eric Chun Yong Chan, Revathi Kamaraj, Kishore Kumar Pasikanti, Paul C. Ho, A.B. Alexandroff, Andrew M. Jackson, Ye Zhang and G. D. CHISHOLM and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Cancer Research.

In The Last Decade

Kesavan Esuvaranathan

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kesavan Esuvaranathan Singapore 22 569 558 304 255 160 64 1.3k
John A. Taylor United States 25 701 1.2× 846 1.5× 420 1.4× 299 1.2× 284 1.8× 84 2.0k
Toru Shimazui Japan 27 1.1k 2.0× 638 1.1× 465 1.5× 98 0.4× 160 1.0× 111 2.3k
Phei‐Lang Chang Taiwan 25 732 1.3× 495 0.9× 566 1.9× 108 0.4× 236 1.5× 87 1.9k
Noboru Hara Japan 20 467 0.8× 302 0.5× 615 2.0× 89 0.3× 104 0.7× 106 1.4k
John L. Phillips United States 18 621 1.1× 316 0.6× 332 1.1× 40 0.2× 112 0.7× 53 1.3k
Yonghua Wang China 19 385 0.7× 311 0.6× 239 0.8× 202 0.8× 24 0.1× 68 1.1k
Yasushi Yamada Japan 17 494 0.9× 135 0.2× 277 0.9× 72 0.3× 55 0.3× 75 1.1k
Xiaokun Zhao China 23 903 1.6× 348 0.6× 352 1.2× 144 0.6× 138 0.9× 97 1.8k
Takayuki Goto Japan 16 300 0.5× 213 0.4× 260 0.9× 123 0.5× 29 0.2× 113 944
Sherry L. Spinelli United States 25 725 1.3× 132 0.2× 137 0.5× 232 0.9× 20 0.1× 49 1.9k

Countries citing papers authored by Kesavan Esuvaranathan

Since Specialization
Citations

This map shows the geographic impact of Kesavan Esuvaranathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kesavan Esuvaranathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kesavan Esuvaranathan more than expected).

Fields of papers citing papers by Kesavan Esuvaranathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kesavan Esuvaranathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kesavan Esuvaranathan. The network helps show where Kesavan Esuvaranathan may publish in the future.

Co-authorship network of co-authors of Kesavan Esuvaranathan

This figure shows the co-authorship network connecting the top 25 collaborators of Kesavan Esuvaranathan. A scholar is included among the top collaborators of Kesavan Esuvaranathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kesavan Esuvaranathan. Kesavan Esuvaranathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahmat, Juwita N., Yew Koon Lim, Revathi Kamaraj, et al.. (2024). Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Response to Bacillus Calmette–Guérin Immunotherapy in Bladder Cancer Patients. International Journal of Molecular Sciences. 25(16). 8947–8947. 1 indexed citations
2.
Esuvaranathan, Kesavan, et al.. (2022). UBC®Rapid Is Sensitive in Detecting High-Grade Bladder Urothelial Carcinoma and Carcinoma in situ in Asian Population. Urologia Internationalis. 107(1). 29–34. 3 indexed citations
3.
4.
Lim, Yew Koon, Henry C. C. Lim, Yiong Huak Chan, et al.. (2018). The Role of Vitamin D Receptor Polymorphisms in Predicting the Response to Therapy for Nonmuscle Invasive Bladder Carcinoma. The Journal of Urology. 200(4). 737–742. 3 indexed citations
5.
Esuvaranathan, Kesavan, et al.. (2017). A Murine Orthotopic Bladder Tumor Model and Tumor Detection System. Journal of Visualized Experiments. 7 indexed citations
6.
Ang, Wei Xia, Ying Zhao, Chunxiao Wu, et al.. (2016). Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy. Scientific Reports. 6(1). 32–34. 13 indexed citations
7.
Esuvaranathan, Kesavan, et al.. (2013). An automated Pearson's correlation change classification (APC3) approach for GC/MS metabonomic data using total ion chromatograms (TICs). The Analyst. 138(10). 2883–2883. 1 indexed citations
8.
Bhullar, Jasneet Singh, Thomas Paulraj Thamboo, & Kesavan Esuvaranathan. (2011). Unique Case of Tubulocystic Carcinoma of the Kidney With Sarcomatoid Features: A New Entity. Urology. 78(5). 1071–1072. 23 indexed citations
9.
Esuvaranathan, Kesavan, et al.. (2011). Tumor and Microenvironment Modification during Progression of Murine Orthotopic Bladder Cancer. SHILAP Revista de lepidopterología. 2011. 1–11. 24 indexed citations
10.
Chiong, Edmund, Ratha Mahendran, Yiong Huak Chan, et al.. (2010). NRAMP1 and hGPX1 Gene Polymorphism and Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer. European Urology. 59(3). 430–437. 30 indexed citations
11.
Pasikanti, Kishore Kumar, Shirong Cai, Ratha Mahendran, et al.. (2010). Metabolic footprinting of tumorigenic and nontumorigenic uroepithelial cells using two-dimensional gas chromatography time-of-flight mass spectrometry. Analytical and Bioanalytical Chemistry. 398(3). 1285–1293. 25 indexed citations
12.
Chiong, Edmund & Kesavan Esuvaranathan. (2009). New therapies for non-muscle-invasive bladder cancer. World Journal of Urology. 28(1). 71–78. 8 indexed citations
13.
Wong, Alvin, et al.. (2008). Debulking nephrectomy followed by a “watch and wait” approach in metastatic renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 27(2). 149–154. 18 indexed citations
14.
15.
Mahendran, Ratha, et al.. (2004). Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors.. International Journal of Molecular Medicine. 14(4). 713–7. 7 indexed citations
16.
Wu, Qinghui, Ratha Mahendran, & Kesavan Esuvaranathan. (2003). Nonviral cytokine gene therapy on an orthotopic bladder cancer model.. PubMed. 9(12). 4522–8. 27 indexed citations
17.
Mahendran, Ratha, et al.. (2001). Transfection of urothelial cells using methyl-β-cyclodextrin solubilized cholesterol and Dotap. Gene Therapy. 8(10). 760–768. 12 indexed citations
18.
Gan, Yunn‐Hwen, et al.. (1999). Evaluation of Lymphocytic Responses after Treatment with Bacillus Calmette-Guerin and Interferon-α 2b for Superficial Bladder Cancer. Clinical Immunology. 90(2). 230–237. 9 indexed citations
19.
Tan, Hao Yang, et al.. (1997). A Community Based Study of Prostatic Symptoms in Singapore. The Journal of Urology. 890–893. 2 indexed citations
20.
Zhang, Ye, Hoon Eng Khoo, & Kesavan Esuvaranathan. (1997). Effects of bacillus Calmette-Guérin and interferon-α-2B on human bladder cancerin vitro. International Journal of Cancer. 71(5). 851–857. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Taylor Breakdown of academic impact, for papers by Toru Shimazui Breakdown of academic impact, for papers by Phei‐Lang Chang Breakdown of academic impact, for papers by Noboru Hara Breakdown of academic impact, for papers by John L. Phillips Breakdown of academic impact, for papers by Yonghua Wang Breakdown of academic impact, for papers by Yasushi Yamada Breakdown of academic impact, for papers by Xiaokun Zhao Breakdown of academic impact, for papers by Takayuki Goto Breakdown of academic impact, for papers by Sherry L. Spinelli
Rankless by CCL
2026